bookmark

(1) Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study : COVID19


тэги

Пользователи данного ресурса

  • @bshanks

Комментарии и рецензии